Cedarburg Hauser adds plant capacity

Wednesday, September 26, 2012 09:32 AM

Cedarburg Hauser Pharmaceuticals (CHP), a Grafton, Wisc.-based contract development and manufacturing organization, has expanded the capacity of its active pharmaceutical ingredient (API) manufacturing plant in Wisconsin.

The expansion efforts are a result of an increased demand for contract manufacturing of commercial APIs and are accompanied by additional upgrades aimed at improving safety and GMP systems.

“These improvements increase our total reactor capacity by nearly 50%,” said John Flahive, CHP’s newly hired director of operations. “We have also added a reactor and chiller that allow for cryogenic reactions in our GMP labs.”

In addition to the new reactors, CHP has also made improvements to the air handling systems in the GMP manufacturing suites, installed a reverse osmosis water system, improved isolation capabilities and upgraded their Emerson DeltaV Digital Automation System.

“The added reactor capacity and upgrades to existing safety and GMP systems are the latest example of Cedarburg Hauser’s continued commitment to serving the commercial API marketplace,” said Tony Laughrey, CEO of CHP. “The flexibility afforded by the additional reactor capacity allows us to better meet our customer’s on-time and on-budget requirements.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

May 20

IRB consolidation trend continues, as private equity firm Audax buys majority stake in Chesapeake

Quintiles, Merck Serono ink exclusive partnership

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

20 innovators changing the face of the clinical trials industry
The CenterWatch Monthly honors individuals, teams and companies for their forward-thinking ideas and their ability to implement them.

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs